CME Group Heading Into Q3 With Solid Results But No Clear Re-Rating Catalyst

Impact · against what's priced in

The article provides no catalyst for CME Group as the reported financial strength and recurring revenue are already baked into the stock's premium valuation. The lack of a clear re-rating catalyst confirms that current price levels already assume the durability of the business model.

CME+0.00: Already priced in
The price assumes: The current 64.3% free-cash-flow margin and 86.1% gross margin sustained indefinitely
The article's mention of 'resilient margins' and 'robust operating and financial results' confirms the stability the market already assumes is embedded in the 22.04x forward P/E.
What CME's price assumes · Aug 27

CME Group Heading Into Q3 With Solid Results But No Clear Re-Rating Catalyst

CMENew
trading volume▲250%
valuation
exchanges
financial services
market data
revenue

Top 2 movers · tap to explore

CME Group Heading Into Q3 With Solid Results But No Clear Re-Rating Catalyst

What matters in this story

WhiteHorse Finance: 15% Yield Sustainable With Range-Bound Trading Until NII Grows

CME Group Heading Into Q3 With Solid Results But No Clear Re-Rating Catalyst

What matters in this story

WhiteHorse Finance: 15% Yield Sustainable With Range-Bound Trading Until NII Grows

How each ticker is affected

Track these names every morning.

When I saw Goldman's price target on SpaceX I said, there's some rigor to this analysis: Jim Cramer

Jensen Huang Said Nvidia Now Has "a Lot Greater Visibility" Into Demand, Letting It Forecast a Full Year Ahead for the First Time Ever. Does That Confidence Justify Nvidia's Premium Valuation?

Bristol-Myers Squibb: Balanced Segment Growth, The Pullback Is An Opportunity

Here's Why Abercrombie & Fitch (ANF) Fell More Than Broader Market

CME Group Heading Into Q3 With Solid Results But No Clear Re-Rating Catalyst

What matters in this story

Next reads from the same story arc

WhiteHorse Finance: 15% Yield Sustainable With Range-Bound Trading Until NII Grows

CME Group Heading Into Q3 With Solid Results But No Clear Re-Rating Catalyst

What matters in this story

Next reads from the same story arc

WhiteHorse Finance: 15% Yield Sustainable With Range-Bound Trading Until NII Grows

How each ticker is affected

Track these names every morning.

When I saw Goldman's price target on SpaceX I said, there's some rigor to this analysis: Jim Cramer

Jensen Huang Said Nvidia Now Has "a Lot Greater Visibility" Into Demand, Letting It Forecast a Full Year Ahead for the First Time Ever. Does That Confidence Justify Nvidia's Premium Valuation?

Bristol-Myers Squibb: Balanced Segment Growth, The Pullback Is An Opportunity

Here's Why Abercrombie & Fitch (ANF) Fell More Than Broader Market